Clinical Trial Update: Effect of Perioperative Oral Rifaximin on Early Graft Dysfunction in Adult Living Donor Liver Transplant [NA]

View source ↗

Summary

A clinical trial is evaluating whether perioperative oral rifaximin reduces early graft dysfunction in adult living donor liver transplant recipients; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Chronic Liver Disease | NA | Status: RECRUITING